AVITA Medical, Inc. (RCEL) Tops Q2 EPS by 5c; Offers Guidance

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q2 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $20.08 million.

GUIDANCE:

AVITA Medical, Inc. sees FY2026 revenue of $86-89 million, versus the consensus of $83.09 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c